Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort

G. S. Alarcón, Manuel Francisco Ugarte Gil, G. Pons-Estel, L. M. Vilá, J. D. Reveille, G. McGwin

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences